Literature DB >> 16148050

Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathway.

Vivian Y Lee1, Clara Schroedl, Joslyn K Brunelle, Leonard J Buccellato, Ozkan I Akinci, Hideaki Kaneto, Colleen Snyder, James Eisenbart, G R Scott Budinger, Navdeep S Chandel.   

Abstract

Exposure to bleomycin in rodents induces lung injury and fibrosis. Alveolar epithelial cell death has been hypothesized as an initiating mechanism underlying bleomycin-induced lung injury and fibrosis. In the present study we evaluated the contribution of mitochondrial and receptor-meditated death pathways in bleomycin-induced death of mouse alveolar epithelial cells (MLE-12 cells) and primary rat alveolar type II cells. Control MLE-12 cells and primary rat alveolar type II cells died after 48 h of exposure to bleomycin. Both MLE-12 cells and rat alveolar type II cells overexpressing Bcl-X(L) did not undergo cell death in response to bleomycin. Dominant negative Fas-associating protein with a death domain failed to prevent bleomycin-induced cell death in MLE-12 cells. Caspase-8 inhibitor CrmA did not prevent bleomycin-induced cell death in primary rat alveolar type II cells. Furthermore, fibroblast cells deficient in Bax and Bak, but not Bid, were resistant to bleomycin-induced cell death. To determine whether the stress kinase JNK was an upstream regulator of Bax activation, MLE-12 cells were exposed to bleomycin in the presence of an adenovirus encoding a dominant negative JNK. Bleomycin-induced Bax activation was prevented by the expression of a dominant negative JNK in MLE-12 cells. Dominant negative JNK prevented cell death in MLE-12 cells and in primary rat alveolar type II cells exposed to bleomycin. These data indicate that bleomycin induces cell death through a JNK-dependent mitochondrial death pathway in alveolar epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148050     DOI: 10.1152/ajplung.00340.2004

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  27 in total

1.  Toll interacting protein protects bronchial epithelial cells from bleomycin-induced apoptosis.

Authors:  Xiaoyun Li; Sharon E Kim; Ting-Yun Chen; Juan Wang; Xia Yang; Tracy Tabib; Jiangning Tan; Brandon Guo; Sonia Fung; Jing Zhao; John Sembrat; Mauricio Rojas; Sruti Shiva; Robert Lafyatis; Claudette St Croix; Jonathan K Alder; Y Peter Di; Daniel J Kass; Yingze Zhang
Journal:  FASEB J       Date:  2020-06-28       Impact factor: 5.191

2.  Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization.

Authors:  M J Gold; P R Hiebert; H Y Park; D Stefanowicz; A Le; M R Starkey; A Deane; A C Brown; G Liu; J C Horvat; Z A Ibrahim; M B Sukkar; P M Hansbro; C Carlsten; S VanEeden; D D Sin; K M McNagny; D A Knight; J A Hirota
Journal:  Mucosal Immunol       Date:  2015-10-28       Impact factor: 7.313

3.  Hsp27 protects against ischemic brain injury via attenuation of a novel stress-response cascade upstream of mitochondrial cell death signaling.

Authors:  R Anne Stetler; Guodong Cao; Yanqin Gao; Feng Zhang; Suping Wang; Zhongfang Weng; Peter Vosler; Lili Zhang; Armando Signore; Steven H Graham; Jun Chen
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

4.  Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis.

Authors:  Sandra Cabrera; Mariana Maciel; Iliana Herrera; Teresa Nava; Fabián Vergara; Miguel Gaxiola; Carlos López-Otín; Moisés Selman; Annie Pardo
Journal:  Autophagy       Date:  2015-04-03       Impact factor: 16.016

5.  Angiotensin II and pulmonary fibrosis, a new twist on an old story.

Authors:  G R Scott Budinger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-01       Impact factor: 5.464

6.  Contribution of alveolar type II cell-derived cyclooxygenase-2 to basal airway function, lung inflammation, and lung fibrosis.

Authors:  Jennifer Cheng; Ryan T Dackor; J Alyce Bradbury; Hong Li; Laura M DeGraff; Lee K Hong; Debra King; Fred B Lih; Artiom Gruzdev; Matthew L Edin; Gregory S Travlos; Gordon P Flake; Kenneth B Tomer; Darryl C Zeldin
Journal:  FASEB J       Date:  2015-09-22       Impact factor: 5.191

7.  Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis.

Authors:  Bruce D Uhal; Xiaopeng Li; Anita Xue; Xu Gao; Amal Abdul-Hafez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-06-10       Impact factor: 5.464

8.  Proapoptotic Bid is required for pulmonary fibrosis.

Authors:  G R Scott Budinger; Gökhan M Mutlu; James Eisenbart; Alyson C Fuller; Amy A Bellmeyer; Christina M Baker; Mindy Wilson; Karen Ridge; Terrence A Barrett; Vivian Y Lee; Navdeep S Chandel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

9.  Neuropeptide substance P attenuates hyperoxia-induced oxidative stress injury in type II alveolar epithelial cells via suppressing the activation of JNK pathway.

Authors:  Bo Huang; Hongmin Fu; Ming Yang; Fang Fang; Fengwu Kuang; Feng Xu
Journal:  Lung       Date:  2009-09-30       Impact factor: 2.584

10.  A review of current and novel therapies for idiopathic pulmonary fibrosis.

Authors:  Rokhsara Rafii; Maya M Juarez; Timothy E Albertson; Andrew L Chan
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.